Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Major Japan Retailers Enter OTC On-Line Sales Market After SC Ruling

This article was originally published in PharmAsia News

Executive Summary

Some of Japan's major retail chains, such as Aeon and Bic Camera are entering the market of on-line sales of over-the-counter drugs in the wake of the Supreme Court ruling that eased the ban on them.

Some of Japan's major retail chains, such as Aeon and Bic Camera are entering the market of on-line sales of over-the-counter drugs in the wake of the Supreme Court ruling that eased the ban on them. Aeon has expanded from Category 3 drugs, those deemed the least risky, into Category 2 drugs such as cold medicines. It says 127 of its stores will handle on-line sales of 800 drugs in the category. Bic Camera is just beginning Category 3 sales and expects to expand to Category 2 within the year. Kenko.com and a few other firms began selling wares in the Categories 1 and 2 soon after the court's January ruling. (Click here for more - a subscription may be required)

"Aeon, Bic Camera Lead Retail Move Into On-Line OTC Drug Sales" - Nikkei (Japan) (4/5/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC084194

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel